Dallas, TX -- (SBWIRE) -- 12/08/2010 -- What Will The Pharmaceutical Market Look Like in the Next Five Years?

This research undertaking is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues. While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade. Companies such as Pfizer, Merck and Novartis have been unable to ignore the benefits of investing in biotechnology and have focused on a pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/or through their own in-house research efforts.

Companies such as Amgen and Genzyme, which specialize in biotechnology, are now competing with a growing number of companies and the lines between pharmaceutical and biotechnology specialty companies are becoming more blended; which is a trend expected to continue to grow.

This Kalorama Information market research report, The World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies) captures these trends, extracting sales for all pharmaceutical and biopharmaceutical products (excluding prophylactic vaccines) and providing estimates and forecasts of the world biopharma market.

CHAPTER ONE: EXECUTIVE SUMMARY

Introduction
Scope and Methodology
Potential Market Opportunity
Issues and Trends Affecting Market
Leading Compan

CHAPTER TWO: INTRODUCTION
Global Pharmaceutical Market
Pharmaceutical Research & Development Overview
Clinical Trial Costs

CHAPTER THREE: ISSUES AND TRENDS

Biotechnology Drug Development

Orphan Drugs

Fast Track Drug Status

Other Accelerated Methods for Drug Approval

Pharmaceutical Regulatory Exclusivity

Pediatric Extensions

Biopharmaceutical Industry—Biosimilar (Biogeneric) Development and Exclusivity Legislation

Aging Population

Mergers, Acquisitions, and Collaborations

Contributors To R&D Success

R&D Spending

The Role of Contract Research Organizations

Sustainability in a changing Pharmaceutical Industry

CHAPTER FOUR: WORLDWIDE PHARMACEUTICAL INDUSTRY LEADERS

Introduction

Pfizer, Inc./Wyeth (merged in 2009)

Overview
Financial Performance and Investments
Late Stage Pipeline
Merck & Co., Inc.

Overview
Financial Performance and Investments
Late Stage Pipeline
Novartis AG

Overview
Financial Performance and Investments
Late Stage Pipeline
Roche Ltd.

Overview
Financial Performance and Investments
Late Stage Pipeline
Sanofi-Aventis

Overview
Financial Performance and Investments
Late Stage Pipeline
AstraZeneca plc

Overview
Financial Performance and Investments
Late Stage Pipeline
GlaxoSmithKline plc

Overview
Financial Performance and Investments
Late Stage Pipeline
Johnson & Johnson

Overview
Financial Performance and Investments
Late Stage Pipeline
Eli Lilly & Company

Overview
Financial Performance and Investments
Late Stage Pipeline
Bristol-Myers Squibb Company

Overview
Financial Performance and Investments
Late Stage Pipeline
Abbott Laboratories

Overview
Financial Performance and Investments
Late Stage Pipeline
Takeda Pharmaceutical Co., Ltd.

Overview
Financial Performance and Investments
Late Stage Pipeline
Bayer AG

Overview
Financial Performance and Investments
Late Stage Pipeline
Amgen, Inc.

Overview
Financial Performance and Investments
Late Stage Pipeline
Boehringer Ingelheim GmbH

Overview
Financial Performance and Investments
Late Stage Pipeline
TEVA Pharmaceutical Industries, Ltd.

Overview
Financial Performance and Investments
Late Stage Pipeline
Astellas

Overview
Financial Performance and Investments
Late Stage Pipeline
Daiichi Sankyo

Overview
Financial Performance and Investments
Late Stage Pipeline
Novo Nordisk

Overview
Financial Performance and Investments
Late Stage Pipeline
Eisai

Overview
Financial Performance and Investments
Late Stage Pipeline

CHAPTER FIVE: COMPANIES OF INTEREST

Introduction
Otsuka
Late Stage Pipeline

Merck KGaA

Late Stage Pipeline

Gilead Sciences

Late Stage Pipeline
Mylan

Pipeline
Baxter International

Late Stage Pipeline
Chugai Pharmaceutical Company, Ltd.

Late Stage Pipeline
Mitsubishi Tanabe

Late Stage Pipeline
Servier, Les Laboratories

Pipeline
UCB SA

Late Stage Pipeline
Allergan

Late Stage Pipeline
Forest Laboratories

Late Stage Pipeline
Nycomed International

Late Stage Pipeline
Genzyme Corporation

Late Stage Pipeline
Biogen Idec

Late Stage Pipeline
Hospira

Late Stage Pipeline
Watson

Pipeline
CSL Limited

Late Stage Pipeline
Alcon

Late Stage Pipeline
Shire

Late Stage Pipeline
Celgene Corporation

Late Stage Pipeline
Lundbeck

Late Stage Pipeline
Shionogi & Co., Ltd.

Late Stage Pipeline
Menarini Group

Late Stage Pipeline
Dainippon Sumitomo Pharma, Co., Ltd.

Late Stage Pipeline
Cephalon

Late Stage Pipeline
Actelion

Late Stage Pipeline
Procter & Gamble

Endo Pharmaceuticals

Late Stage Pipeline
Ono Pharmaceutical Co.

Late Stage Pipeline
Purdue Pharma

Late Stage Pipeline
CHAPTER SIX: MARKET FORECAST

Overview

Company Analysis

Pipeline Snapshot: Top 50 Companies

Current Market Value

Market Forecast

CHAPTER SEVEN: BIOPHARMACEUTICAL MARKET

Biopharmaceutical Companies

Biopharmaceutical Market Forecast

ABBREVIATIONS

Browse all : Pharmaceuticals
http://www.reportsnreports.com/market-research/pharmaceuticals/

Browse all : Kalorama Information
http://www.reportsnreports.com/publishers/kalorama-information/

Browse all : Newly Published
http://www.reportsnreports.com/LatestReport.aspx

Related Reports :

Global Small Wind (50-350kW) Market Analysis and Forecasts to 2015
http://www.reportsnreports.com/reports/25503-global-small-wind-50-350kw-market-analysis-and-forecasts-to-201.html

Global Small Wind (50-350kW) Power Market Analysis and Forecasts to 2015
http://www.reportsnreports.com/reports/16049-global-small-wind-50-350kw-power-market-analysis-and-forecasts-.html

Research Report on Top 50 of Global Tire Manufacturers, 2009-2010
http://www.reportsnreports.com/reports/10300-research-report-on-top-50-of-global-tire-manufacturers-2009-2010.html

3D IC & TSV Top 50 Profiles
http://www.reportsnreports.com/reports/17282-3d-ic-tsv-top-50-profiles.html

World E-Paper Display Market: Technologies, Applications, Trends & Forecast (2010 - 2015)
http://www.reportsnreports.com/reports/41375-world-e-paper-display-market-technologies-applications-trends-.html

About ReportsnReports
ReportsnReports is comprising of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.

Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.

Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsnreports.com/
Blog: http://reportsnreports.wordpress.com/

ReportsnReports announce World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
http://www.reportsnreports.com/reports/26078-world-pharmaceutical-and-biopharmaceutical-market-2010-2015-pip.html

Original Source : Pharmaceutical and Biopharmaceutical Market
http://www.reportsnreports.com/reports/26078-world-pharmaceutical-and-biopharmaceutical-market-2010-2015-pip.html

Buy Now : Market Research
http://www.reportsnreports.com/

Browse complete Report at : World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
http://www.reportsnreports.com/reports/26078-world-pharmaceutical-and-biopharmaceutical-market-2010-2015-pip.html